Overview

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Lumicell, Inc.
Collaborator:
National Cancer Institute (NCI)